Helen Chung
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Oncology
- Neurology top 10%
- Co-authors
- Cheryl ChanRobert J. HayesBassil I. DahiyatWei DangJost VielmetterSean C. YoderDavid F. CarmichaelOmid Vafa
- Topics
- Neuroblastoma Research and Treatments (3 papers)Economic and Financial Impacts of Cancer (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Helen Chung
8 papers receiving 839 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Molecular Biology 502
- Radiology, Nuclear Medicine and Imaging 498
- Immunology 292
- Oncology 217
- Neurology 118
Countries citing papers authored by Helen Chung
This map shows the geographic impact of Helen Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Chung more than expected).
Fields of papers citing papers by Helen Chung
This network shows the impact of papers produced by Helen Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Chung. The network helps show where Helen Chung may publish in the future.
Co-authorship network of co-authors of Helen Chung
This figure shows the co-authorship network connecting the top 25 collaborators of Helen Chung. A scholar is included among the top collaborators of Helen Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Chung. Helen Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | Engineered antibody Fc variants with enhanced effector functionbreakdown → | 590 |
| 5 | 46 | |
| 6 | In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma. | 8 |
| 7 | Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. | 206 |
| 8 | 20 |
About Helen Chung
Helen Chung is a scholar working on Neurology, Genetics and Hematology, having authored 8 papers that have together received 895 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (498 citations), Immunology (292 citations) and Oncology (217 citations). Helen Chung has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Cheryl Chan, Robert J. Hayes, Bassil I. Dahiyat, Wei Dang, Jost Vielmetter, Sean C. Yoder, David F. Carmichael, Omid Vafa, Sher Karki and Araz Eivazi. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.